Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-12-20FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approves a supplemental application for risperidone from Amici Pharma, Inc.
-
FDA approval · 2012-12-19FDA Approved: RISPERIDONE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application from Amneal Pharmaceuticals LLC for risperidone (generic), marking an update to its approval und…
-
FDA approval · 2012-12-12FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for risperidone submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Yoga in Unipolar and Bipolar Disorders [NA]
A completed clinical trial evaluated yoga as an intervention for bipolar disorder and depressive disorders, including major depressive disor…
-
CLINICAL_TRIALS trial_result · 2012-12-03Clinical Trial Update: The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning [Phase 3]
Phase 3 trial evaluating the impact of galantamine hydrobromide as an adjunct to electroconvulsive therapy on mood and cognitive outcomes in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2012-11-29Clinical Trial Update: Effects of Electroconvulsive Therapy (ECT) in Bipolar Depression
The McLean Hospital-sponsored trial evaluating electroconvulsive therapy for bipolar depression has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children [Phase 4]
Phase 4 study comparing risperidone with other atypical antipsychotics in children to assess safety and impact on growth and sexual maturati…
-
FDA approval · 2012-11-27FDA Approved: RISPERIDONE — Supplemental Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's generic risperidone through an ANDA, authorizing the generic product for the same indications as the brand.
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone [NA]
A completed clinical trial evaluated diabetes risk factors in people with schizophrenia or bipolar disorder after switching to ziprasidone; …
-
FDA approval · 2012-11-13FDA Approved: EQUETRO — Supplemental Application (Validus Pharmaceuticals LLC)
The FDA approved a supplemental application for EQUETRO (carbamazepine) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder [Phase 2]
Phase 2 trial evaluating erythropoietin for depressive symptoms and neurocognitive deficits in mood disorders; the study has completed.
-
FDA approval · 2012-11-08FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved Allergan's supplemental application for SAPHRIS (asenapine), resulting in labeling changes for the antipsychotic.
-
FDA approval · 2012-10-29FDA Approved: RISPERIDONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for risperidone by Sun Pharmaceutical Industries, Inc. (ANDA 078474).
-
CLINICAL_TRIALS trial_result · 2012-10-26Clinical Trial Update: Functional Assessment of Patients With Acute Bipolar Depression After 8 Months of Follow-up
The update provides functional outcome data from AstraZeneca's trial in patients with acute bipolar depression after 8 months of follow-up.
-
FDA approval · 2012-10-22FDA Approved: RISPERIDONE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for risperidone from Aurobindo Pharma Limited (generic risperidone).
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients [Phase 4]
This clinical trial update describes a Phase 4 study to test whether adding lithium or aripiprazole to quetiapine enhances treatment respons…
-
FDA approval · 2012-10-18FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' supplemental application for risperidone under an ANDA, confirming approval of a change associated…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder [Phase 3]
Phase 3 trial results for quetiapine fumarate (SEROQUEL) in adolescent patients with schizophrenia and Bipolar I Disorder. The study has com…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder [Phase 3]
Phase 3 trial evaluated quetiapine XR as an adjunct to mood stabilizers for controlling subsyndromal symptoms in bipolar disorder; the study…
-
CLINICAL_TRIALS research · 2012-09-17Clinical Trial Update: IBIS: Italian Burden of Illness on Schizophrenia & Bipolar Disorder
The IBIS study in Italy assessing the burden of illness for schizophrenia and bipolar disorder has completed, sponsored by AstraZeneca.
-
FDA approval · 2012-09-12FDA Approved: OLANZAPINE — Original Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved the original application for olanzapine from Jubilant Cadista Pharmaceuticals Inc., providing a generic version of the antipsyc…
-
CLINICAL_TRIALS trial_result · 2012-09-11Clinical Trial Update: Clinical Trial of a Nutritional Supplement in Adults With Bipolar Disorder [Phase 2]
A Phase 2 clinical trial of a nutritional supplement in adults with bipolar disorder was terminated, with results posted in 2012.
-
CLINICAL_TRIALS research · 2012-09-05Clinical Trial Update: Evaluation of Brain MRI and Clinical Characteristics of Adolescents With Bipolar Disorder and Children of Parents With Bipolar Disorder
This clinical trial update describes an ongoing study evaluating brain MRI findings and clinical characteristics in adolescents with bipolar…
-
FDA approval · 2012-09-05FDA Approved: ZIPRASIDONE — Original Application (Chartwell RX, LLC)
FDA approved an original application for ziprasidone from Chartwell RX, LLC, enabling a new generic version of the antipsychotic.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Aripiprazole Open-Label, Safety and Tolerability Study [Phase 3]
This is an open-label Phase 3 study of aripiprazole assessing safety and tolerability in schizophrenia and bipolar disorder; results were po…